Owner Baylor College of Medicine Opexa Pharmaceuticals Inc.

Inventors Zang, Jingwu Zhang

Agent Shelston IP

Pub. Number AU-B-2003258090

PCT Number PCT/US03/24548

PCT Pub. Number WO2004/015070

Priority 60/402,521 08.08.02 US

Filing date 6 August 2003

Wipo publication date 25 February 2004

Acceptance publication date 22 July 2010

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/26 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Lymph

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C12N 5/0783 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - T cells

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/564 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds